Cargando…
In vivo PDX CRISPR/Cas9 screens reveal mutual therapeutic targets to overcome heterogeneous acquired chemo-resistance
Resistance towards cancer treatment represents a major clinical obstacle, preventing cure of cancer patients. To gain mechanistic insights, we developed a model for acquired resistance to chemotherapy by treating mice carrying patient derived xenografts (PDX) of acute lymphoblastic leukemia with wid...
Autores principales: | Wirth, Anna-Katharina, Wange, Lucas, Vosberg, Sebastian, Henrich, Kai-Oliver, Rausch, Christian, Özdemir, Erbey, Zeller, Christina M., Richter, Daniel, Feuchtinger, Tobias, Kaller, Markus, Hermeking, Heiko, Greif, Philipp A., Senft, Daniela, Jurinovic, Vindi, Bahrami, Ehsan, Jayavelu, Ashok Kumar, Westermann, Frank, Mann, Matthias, Enard, Wolfgang, Herold, Tobias, Jeremias, Irmela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712105/ https://www.ncbi.nlm.nih.gov/pubmed/36333584 http://dx.doi.org/10.1038/s41375-022-01726-7 |
Ejemplares similares
-
Adverse stem cell clones within a single patient’s tumor predict clinical outcome in AML patients
por: Zeller, Christina, et al.
Publicado: (2022) -
Combined proteomics and CRISPR‒Cas9 screens in PDX identify ADAM10 as essential for leukemia in vivo
por: Bahrami, Ehsan, et al.
Publicado: (2023) -
Plasticity in growth behavior of patients’ acute myeloid leukemia stem cells growing in mice
por: Ebinger, Sarah, et al.
Publicado: (2020) -
X‐linked inhibitor of apoptosis protein represents a promising therapeutic target for relapsed/refractory ALL
por: Carlet, Michela, et al.
Publicado: (2022) -
Priority-Lasso: a simple hierarchical approach to the prediction of clinical outcome using multi-omics data
por: Klau, Simon, et al.
Publicado: (2018)